The era of free Covid vaccines in the US may be coming to an end, and pharmaceutical companies like Moderna are considering a price of $110 to $130 per jab, the Wall Street Journal reports. That’s more than four times the cost the government was paying for the treatments under federal contracts.
Throughout the pandemic, the federal government has spent more than $30bn incentivising the development, then securing the purchase and distribution, of coronavirus vaccines, effectively making them temporarily free at the point of treatment, according to a Kaiser Family Foundation (KFF) analysis.
